Clinical trials in rare disease: challenges and opportunities
EF Augustine, HR Adams… - Journal of child …, 2013 - journals.sagepub.com
The neuronal ceroid lipofuscinoses constitute one of many groups of rare childhood
diseases for which disease-modifying treatments are nonexistent. Disease-specific barriers …
diseases for which disease-modifying treatments are nonexistent. Disease-specific barriers …
[HTML][HTML] Sanfilippo syndrome: consensus guidelines for clinical care
N Muschol, R Giugliani, SA Jones, J Muenzer… - Orphanet Journal of …, 2022 - Springer
Sanfilippo syndrome is a group of rare, complex, and progressive neurodegenerative
lysosomal storage disorders that is characterized by childhood dementia. The clinical …
lysosomal storage disorders that is characterized by childhood dementia. The clinical …
[HTML][HTML] Parents' experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS)
S Somanadhan, PJ Larkin - Orphanet journal of rare diseases, 2016 - Springer
Background Many rare diseases of childhood are life-threatening and chronically
debilitating, so living with a rare disease is an on-going challenge for patients and their …
debilitating, so living with a rare disease is an on-going challenge for patients and their …
[HTML][HTML] Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations—Neurological signs and symptoms
EG Shapiro, SA Jones, ML Escolar - Molecular genetics and metabolism, 2017 - Elsevier
The mucopolysaccharidoses (MPS) are a group of rare, inherited lysosomal storage
disorders, caused by mutations in lysosomal enzymes involved in the degradation of …
disorders, caused by mutations in lysosomal enzymes involved in the degradation of …
Polysymptomatology in pediatric patients receiving palliative care based on parent-reported data
Importance Pediatric palliative care treats patients with a wide variety of advanced illness
conditions, often with substantial levels of pain and other symptoms. Clinical and research …
conditions, often with substantial levels of pain and other symptoms. Clinical and research …
[HTML][HTML] Therapy development for the mucopolysaccharidoses: updated consensus recommendations for neuropsychological endpoints
JH van der Lee, J Morton, HR Adams, L Clarke… - Molecular Genetics and …, 2020 - Elsevier
Neurological dysfunction represents a significant clinical component of many of the
mucopolysaccharidoses (also known as MPS disorders). The accurate and consistent …
mucopolysaccharidoses (also known as MPS disorders). The accurate and consistent …
Parental social support, coping strategies, resilience factors, stress, anxiety and depression levels in parents of children with MPS III (Sanfilippo syndrome) or children …
S Grant, E Cross, JE Wraith, S Jones, L Mahon… - Journal of inherited …, 2013 - Springer
Abstract Mucopolysaccharidosis type III (MPS III, Sanfilippo syndrome) is a lysosomal
storage disorder, caused by a deficiency in one of four enzymes involved in the catabolism …
storage disorder, caused by a deficiency in one of four enzymes involved in the catabolism …
[HTML][HTML] The impact of severe rare chronic neurological disease in childhood on the quality of life of families—a study on MLD and PCH2
L Ammann-Schnell, S Groeschel, C Kehrer… - Orphanet journal of rare …, 2021 - Springer
Background Rare and severe neurological disorders in childhood not only heavily affect the
life perspective of the patients, but also their caregivers and families. The aim of this study …
life perspective of the patients, but also their caregivers and families. The aim of this study …
[HTML][HTML] The psychosocial impact of childhood dementia on children and their parents: a systematic review
SM Nevin, BC McGill, L Kelada, G Hilton… - Orphanet Journal of …, 2023 - Springer
Background Childhood dementias are a group of rare and ultra-rare paediatric conditions
clinically characterised by enduring global decline in central nervous system function …
clinically characterised by enduring global decline in central nervous system function …
[HTML][HTML] Parent experiences of Sanfilippo syndrome impact and unmet treatment needs: a qualitative assessment
KA Porter, C O'Neill, E Drake, S Parker… - Neurology and …, 2021 - Springer
Abstract Introduction Sanfilippo syndrome (MPS III) is a rare, degenerative condition
characterized by symptoms impacting cognitive ability, mobility, behavior, and quality of life …
characterized by symptoms impacting cognitive ability, mobility, behavior, and quality of life …